Attached files

file filename
10-K - FORM 10-K - Molecular Templates, Inc.d269230d10k.htm
EX-10.2 - 2004 AMENDED AND RESTATED EQUITY INCENTIVE PLAN (AS AMENDED ON MAY 19, 2010) - Molecular Templates, Inc.d269230dex102.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 15D-14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.d269230dex311.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.d269230dex321.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 15D-14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.d269230dex312.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.d269230dex322.htm
EXCEL - IDEA: XBRL DOCUMENT - Molecular Templates, Inc.Financial_Report.xls
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - Molecular Templates, Inc.d269230dex232.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-174844, No. 333-169689, 333-162719 and 333-153475) and Registration Statement on Form S-8 (No. 333-173047, No. 333-167260, 333-164865, No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) pertaining to the 2004 Amended and Restated Equity Incentive Plan and Amended and Restated 2004 Employee Stock Purchase Plan of Threshold Pharmaceuticals, Inc. of our report dated March 15, 2012, with respect to the consolidated financial statements of Threshold Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2011.

/s/ Ernst & Young LLP

San Jose, California

March 15, 2012